🇺🇸 Mirum Pharmaceuticals, Inc.MIRM
Get Mirum Pharmaceuticals, Inc. filings on Telegram the moment they are published.
Follow Mirum Pharmaceuticals, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 8.01
Overview: Met the primary endpoint in the Phase 3 AZURE-4 study evaluating brelovitug for chronic HDV, with 59% of 300 mg QW patients achieving efficacy.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest